本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

TriSalus Life Sciences Inc.

5.51
+0.32006.17%
成交量:2.79萬
成交額:15.23萬
市值:2.08億
市盈率:-4.84
高:5.58
開:5.22
低:5.22
收:5.19
資料載入中...
2024/04/16

重要事件披露

Form 8-K - Current report
2024/04/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/11

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/04/01

重要事件披露

Form 8-K - Current report
2024/03/12

重要事件披露

Form 8-K - Current report
2024/01/25

重要事件披露

Form 8-K - Current report
2024/01/05

重要事件披露

Form 8-K - Current report
2023/12/21

SEC問詢函

Form CORRESP - Correspondence
2023/12/21

SEC問詢函

Form CORRESP - Correspondence
2023/12/15

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/12/15

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/12/14

SEC問詢函

Form CORRESP - Correspondence
2023/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/14

重要事件披露

Form 8-K - Current report
2023/10/19

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/10/18

SEC問詢函

Form CORRESP - Correspondence
2023/10/16

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/10/03

重要事件披露

Form 8-K - Current report
2023/09/02

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/09/01

重要事件披露

Form 8-K - Current report